203641 | BMP-2, Human, Recombinant, E. coli

203641
Le prix n'a pas pu être récupéré
La quantité minimale doit être un multiple de
À la validation de la commande Plus d'informations
Vous avez sauvegardé ()
 
Demander le prix
Disponibilité limitéeDisponibilité limitée
En stock 
Interrompu(e)
Disponible en quantités limitées
Disponibilité à confirmer
    Pour le restant : Nous vous tiendrons informé
      Pour le restant : Nous vous tiendrons informé
      Nous vous tiendrons informé
      Contacter le Service Clients
      Voir les Prix & la Disponibilité
      Click To Print This Page

      Aperçu

      Replacement Information

      Tableau de caractéristiques principal

      Purity
      ≥95% by SDS-PAGE

      Prix & Disponibilité

      RéférenceDisponibilité Conditionnement Qté Prix Quantité
      203641-2UG
      Récupération des données relatives à la disponibilité...
      Disponibilité limitéeDisponibilité limitée
      En stock 
      Interrompu(e)
      Disponible en quantités limitées
      Disponibilité à confirmer
        Pour le restant : Nous vous tiendrons informé
          Pour le restant : Nous vous tiendrons informé
          Nous vous tiendrons informé
          Contacter le Service Clients

          Ampoule plast. 2 μg
          Prix en cours de récupération
          Le prix n'a pas pu être récupéré
          La quantité minimale doit être un multiple de
          À la validation de la commande Plus d'informations
          Vous avez sauvegardé ()
           
          Demander le prix
          Description
          OverviewRecombinant, human bone morphogenetic protein-2 (BMP-2) expressed in E. coli and purified by proprietary chromatographic methods. BMP-2 is a homodimeric protein that belongs to the transforming growth factor-β (TGF-β) superfamily. BMP-2 is known to regulate diverse fundamental processes during embryonic development. It also plays an important role in cardiac morphogenesis and is expressed in a variety of tissues such as lung, spleen, brain, liver, prostate, ovary, and small intestine.
          Catalogue Number203641
          Brand Family Calbiochem®
          SynonymsBone morphogenetic protein 2 precursor, BMP-2A
          References
          ReferencesCsiszar, A., et al. 2006. Am. J. Pathol. 168, 629.
          Kumagai, T., et al. 2006. Anticancer Res. 26, 293.
          Kumagai, T., et al. 2006. Int. J. Mol. Med. 17, 285.
          Kuo, P.L., et al. 2006. Biol. Pharm. Bull. 29, 119.
          Morin, R., et al. 2006. Biomacromolecules 7, 131.
          Villavicencio, A.T., et al. 2005. J. Neurosurg. Spine 3, 436.
          Product Information
          FormLyophilized
          FormulationLyophilized from sterile 10 mM sodium citrate, pH 3.5.
          Applications
          Biological Information
          Purity≥95% by SDS-PAGE
          Physicochemical Information
          Dimensions
          Materials Information
          Toxicological Information
          Safety Information according to GHS
          Safety Information
          Product Usage Statements
          Storage and Shipping Information
          Ship Code Blue Ice Only
          Toxicity Standard Handling
          Storage -20°C
          Do not freeze Ok to freeze
          Special InstructionsFollowing reconstitution, refrigerate (4°C) for short-term storage or aliquot and freeze (-20°C) for long-term storage. Stock solutions are stable for 2-7 days at 4°C or for up to 6 months at -20°C. Avoid freeze/thaw cycles of solutions.
          Packaging Information
          Transport Information
          Supplemental Information
          Specifications

          Documentation

          Certificats d'analyse

          TitreNuméro de lot
          203641

          Références bibliographiques

          Aperçu de la référence bibliographique
          Csiszar, A., et al. 2006. Am. J. Pathol. 168, 629.
          Kumagai, T., et al. 2006. Anticancer Res. 26, 293.
          Kumagai, T., et al. 2006. Int. J. Mol. Med. 17, 285.
          Kuo, P.L., et al. 2006. Biol. Pharm. Bull. 29, 119.
          Morin, R., et al. 2006. Biomacromolecules 7, 131.
          Villavicencio, A.T., et al. 2005. J. Neurosurg. Spine 3, 436.
          Fiche technique

          Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

          Revision20-May-2008 RFH
          SynonymsBone morphogenetic protein 2 precursor, BMP-2A
          DescriptionRecombinant, human bone morphogenetic protein-2 (BMP-2) expressed in E. coli and purified by proprietary chromatographic methods. BMP-2 is a homodimeric protein that belongs to the transforming growth factor-β (TGF-β) superfamily. BMP-2 is known to regulate diverse fundamental processes during embryonic development. It also plays an important role in cardiac morphogenesis and is expressed in a variety of tissues such as lung, spleen, brain, liver, prostate, ovary, and small intestine.
          FormLyophilized
          FormulationLyophilized from sterile 10 mM sodium citrate, pH 3.5.
          Purity≥95% by SDS-PAGE
          SolubilityReconstitute to ≥100 µg/ml with 20 mM acetic acid containing 0.1% HSA or BSA. Further dilutions can be made in aqueous buffers just prior to use.
          Storage -20°C
          Do Not Freeze Ok to freeze
          Special InstructionsFollowing reconstitution, refrigerate (4°C) for short-term storage or aliquot and freeze (-20°C) for long-term storage. Stock solutions are stable for 2-7 days at 4°C or for up to 6 months at -20°C. Avoid freeze/thaw cycles of solutions.
          Toxicity Standard Handling
          ReferencesCsiszar, A., et al. 2006. Am. J. Pathol. 168, 629.
          Kumagai, T., et al. 2006. Anticancer Res. 26, 293.
          Kumagai, T., et al. 2006. Int. J. Mol. Med. 17, 285.
          Kuo, P.L., et al. 2006. Biol. Pharm. Bull. 29, 119.
          Morin, R., et al. 2006. Biomacromolecules 7, 131.
          Villavicencio, A.T., et al. 2005. J. Neurosurg. Spine 3, 436.